| Literature DB >> 35980409 |
Xiang-Min Li1, Guo-Qing Huang1, Ai-Min Wang1, Li-Ping Zhou1, Xiao-Ye Mo1, Fang-Jie Zhang1.
Abstract
OBJECTIVES: Our goal in this study was to determine 1) whether there are any differences in clinical characteristics between Chinese and Western patients with aortic dissection (AD), and 2) the mortality rate of AD patients in the emergency department (ED) and identify the risk predictors for death.Entities:
Mesh:
Year: 2022 PMID: 35980409 PMCID: PMC9391015 DOI: 10.5811/westjem.2021.7.52525
Source DB: PubMed Journal: West J Emerg Med ISSN: 1936-900X
Gender, classification and age differences between South China and Western populations (IRAD* data).
| South China data (N = 535) | IRAD data | ||
|---|---|---|---|
| Gender | |||
| Male | 422 | 2,964 | <0.0001 |
| Female | 113 | 1,464 | |
| Classification | |||
| Type A AD | 214 | 2,952 | <0.0001 |
| Type B AD | 321 | 1,476 | |
| Age | |||
| Total AD | 54.7±14.1 | 62.2 ±14.5 | All |
| Type A AD | 54.7±13.7 (n = 214) | 61.5±14.6 (n = 2,952) | |
| Type B AD | 58.0±14.2 (n = 321) | 63.6±14.1 (n = 1,476) |
IRAD, International Registry of Aortic Dissection; AD, aortic dissection.
Differences in total hypertension rate in aortic dissection patients.
| South China population | Western population | Total | P value | |
|---|---|---|---|---|
| Hypertension in AD | 358 | 3,247 | 3,605 | <0.01 |
| Non-hypertension in AD | 177 | 1,181 | 1,358 | |
| Hypertension in Type A AD | 137 | 2,089 | 2,226 | <0.0001 |
| Non-hypertension in Type A AD | 77 | 2,952 | 3,029 | |
| Hypertension in Type B AD | 221 | 1,158 | 1,379 | <0.001 |
| Non-hypertension in Type B AD | 100 | 318 | 418 |
AD, aortic dissection.
Patients’ istories.
| Type A AD | Type B AD | P value | |
|---|---|---|---|
| Patients | 214 | 321 | |
| Age | 54.7±13.7 | 58.0±14.2 | <0.01 |
| Gender (male,%) | 157,73.36% | 265,82.55% | <0.01 |
| Connective tissue disease | 1 | 1 | 1.00 |
| Drinking | 12 | 18 | 1.00 |
| History of AD surgery | 6 | 9 | 1.00 |
| Familial AD | 1 | 2 | 1.00 |
| Pregnancy | 2 | 2 | 1.00 |
| Previous cerebral infarction | 5 | 6 | 0.76 |
| COPD | 2 | 5 | 0.71 |
| Smoking | 47 | 65 | 0.67 |
| History of AD without surgery | 1 | 4 | 0.65 |
| Atrial fibrillation | 2 | 1 | 0.57 |
| Bradycardia | 2 | 1 | 0.57 |
| CKD5 | 6 | 13 | 0.49 |
| Scoliosis | 1 | 0 | 0.40 |
| Marfan syndrome | 3 | 1 | 0.31 |
| Diabetes | 8 | 7 | 0.30 |
| Hypertension (%) | 137 (64.02%) | 221 (68.85%) | 0.26 |
| Coronary atherosclerotic heart disease | 18 | 39 | 0.20 |
| History of heart surgery | 4 | 1 | 0.09 |
| Died in ED | 23, 10.75% | 6, 1.87% | <0.0001 |
AD, aortic dissection; COPD, chronic obstructive pulmonary disease; CKD, chronic kidney disease; ED, emergency department.
Signs and symptoms in aortic dissection patients.
| Clinical symptoms | TAAD (N = 214) | TBAD (N = 321) | P value |
|---|---|---|---|
| Chest pain | 109 | 93 | <0.0001 |
| Back pain | 14 | 26 | 0.62 |
| Chest and back pain | 30 | 53 | 0.47 |
| Abdominal pain | 19 | 86 | <0.0001 |
| Chest tightness | 25 | 7 | <0.0001 |
| Dizziness and headache | 6 | 8 | 1.00 |
| Cough | 2 | 2 | 1.00 |
| Hoarseness | 0 | 1 | 1.00 |
| Unclear speech | 0 | 1 | 1.00 |
| Shock | 0 | 1 | 1.00 |
| Hemoptysis | 1 | 3 | 0.65 |
| Hematemesis | 0 | 2 | 0.52 |
| Hematuria | 0 | 2 | 0.52 |
| Obstipation | 0 | 2 | 0.52 |
| Painful urination | 0 | 2 | 0.52 |
| Cardiac arrest | 1 | 0 | 0.40 |
| Twitch | 1 | 0 | 0.40 |
| Asymptomatic | 3 | 10 | 0.26 |
| Vomiting | 4 | 2 | 0.22 |
| Limb weakness or pain | 10 | 8 | 0.22 |
| Abdominal fullness | 0 | 5 | 0.16 |
| Coma | 2 | 0 | 0.16 |
| Neck pain | 2 | 0 | 0.16 |
| Fever | 2 | 0 | 0.16 |
| Bloody stools | 1 | 7 | 0.15 |
| Syncope | 7 | 3 | 0.10 |
| Palpitations | 4 | 1 | 0.09 |
| Onset as new cerebral infarction | 4 | 1 | 0.09 |
| Waist pain | 0 | 6 | 0.09 |
| Weariness | 0 | 6 | 0.09 |
| Post-trauma | 0 | 6 | 0.09 |
| Shortness of breath | 10 | 3 | <0.01 |
| Confusion | 12 | 4 | <0.01 |
| Onset as acute myocardial infarction | 6 | 1 | 0.02 |
TAAD, type A aortic dissection; TBAD, type B aortic dissection.
The differences between surviving and deceased patients in Type A AD.
| Survivor | Deceased | P value | |
|---|---|---|---|
| Age | 54.0±13.7 | 60.1±12.8 | 0.04 |
| WBC | 11.78±0.37 | 14.35±1.23 | 0.04 |
| HGB | 126.2±1.78 | 111.9±8.7 | 0.02 |
| PLT | 181.1±6.30 | 175.9±20.67 | 0.08 |
| NC | 9.71±0.36 | 12.51±1.14 | 0.02 |
| LC | 1.13±0.53 | 0.94±0.09 | 0.28 |
| BS | 7.61±0.16 | 8.77±1.50 | 0.11 |
| BUN | 7.52±0.34 | 13.23±1.45 | <0.0001 |
| Cr | 124.1±9.97 | 247.9±42.95 | <0.001 |
| UA | 384.5±11.74 | 540.9±55.31 | <0.001 |
| TBIL | 17.80±0.93 | 20.90±3.57 | 0.35 |
| TC | 4.36±0.92 | 4.25±0.25 | 0.71 |
| TG | 1.79±0.16 | 1.65±0.20 | 0.79 |
| HDL | 1.09±0.28 | 1.77±0.70 | 0.01 |
| LDL | 2.69±0.56 | 2.48±0.23 | 0.30 |
| CK | 214.1±40.26 | 549.1±278.4 | 0.03 |
| LDH | 289±29.77 | 2278±1517 | <0.0001 |
| CKMB | 19.35±1.98 | 112.6±66.05 | <0.0001 |
| Mb | 155.8±40.39 | 905.4±442.5 | <0.0001 |
| ALT | 64.29±17.76 | 643.5±482 | <0.01 |
| AST | 85.65±27.03 | 743.5±439.2 | <0.0001 |
| CRP | 37.63±4.44 | 28.11±14.94 | 0.61 |
| PT | 15.65±0.71 | 18.92±2.59 | 0.21 |
| APTT | 34.77±1.13 | 49.85±11.26 | <0.01 |
| TT | 202.7±1.46 | 23.66±3.72 | 0.52 |
| FIB | 3.37±0.17 | 2.94±0.49 | 0.47 |
| INR | 1.26±0.64 | 1.53±.024 | 0.23 |
| FDP | 27.53±2.41 | 43.56±10.09 | 0.07 |
| D-dimer | 2.17±0.17 | 4.16±0.87 | <0.01 |
WBC, white blood count; HGB, hemoglobin; PLT, platelet count; NC, neutrophil count; LC, lymphocyte count; BS, blood sugar; BUN, blood urea nitrogen; Cr, creatine levels; UA, urinalysis; TBIL, total bilirubin; TC, total cholesterol; TG, triglycerides; HDL, high-density lipoprotein; LDL, low-density lipoprotein; CK, creatine kinase; LDH, lactate dehydrogenase; CKMB, creatine kinase-MB; Mb, myoglobin; ALT, alanine aminotransferase; AST, aspartate aminotransferase; CRP, C-reactive protein; PT, prothrombin time; APTT, activated partial thromboplastin time; TT, thrombin time; FIB, fibrinogen; INR, international normalized ratio; FDP, fibrin degradation products.
Multivariate logistic regression models for independent factors related to patient deaths.
| P | OR | 95% CI | |
|---|---|---|---|
| BUN | <0.01 | 0.8408 | 0.7459 – 0.9441 |
| LDH | 0.25 | 0.9988 | 0.9949 – 1.000 |
| CKMB | 0.07 | 0.9841 | 0.9644 – 1.001 |
| Mb | 0.23 | 1.001 | 0.9997 – 1.002 |
| AST | 0.33 | 1.002 | 0.9997 – 1.008 |
OR, odds ratio; CI, confidence interval; BUN, blood urea nitrogen; LDH, lactate dehydrogenase; CKMB, creatine kinase-MB; AST, aspartate aminotransferase.